Dyadic and Fermbox Bio Launch Animal-Origin-Free Recombinant DNase I, First Commercialized Product Under Expanded Collaboration.

Wednesday, Mar 4, 2026 7:22 am ET1min read
DYAI--

Dyadic Applied BioSolutions and Fermbox Bio have launched their first commercial product, animal-origin-free Recombinant DNase I (RNase-free), under their expanded collaboration. This product is produced using Dyadic's high-yield fungal microbial expression platforms and Fermbox Bio's scale-up and biomanufacturing capabilities. Recombinant DNase I is used for nucleic-acid clean-up and sample preparation workflows, and is currently available in research grade with a cGMP-grade version in development.

Dyadic and Fermbox Bio Launch Animal-Origin-Free Recombinant DNase I, First Commercialized Product Under Expanded Collaboration.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet